150 related articles for article (PubMed ID: 33305877)
1. Identification of Novel Fragments Binding to the PDZ1-2 Domain of PSD-95.
Zang J; Ye F; Solbak SMØ; Høj LJ; Zhang M; Bach A
ChemMedChem; 2021 Mar; 16(6):949-954. PubMed ID: 33305877
[TBL] [Abstract][Full Text] [Related]
2. An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
Tiwari G; Mohanty D
PLoS One; 2013; 8(8):e71340. PubMed ID: 23951139
[TBL] [Abstract][Full Text] [Related]
3. Rigidified clicked dimeric ligands for studying the dynamics of the PDZ1-2 supramodule of PSD-95.
Eildal JN; Bach A; Dogan J; Ye F; Zhang M; Jemth P; Strømgaard K
Chembiochem; 2015 Jan; 16(1):64-9. PubMed ID: 25407949
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.
Vogrig A; Dorr L; Bouzidi N; Boucherle B; Wattiez AS; Cassier E; Vallon G; Ripoche I; Abrunhosa-Thomas I; Marin P; Nauton L; Thery V; Courteix C; Lian LY; Ducki S
ACS Chem Biol; 2013 Oct; 8(10):2209-16. PubMed ID: 23895101
[TBL] [Abstract][Full Text] [Related]
5. In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95).
Sharma T; Siddiqi MI
J Biomol Struct Dyn; 2019 Mar; 37(5):1241-1253. PubMed ID: 29557723
[TBL] [Abstract][Full Text] [Related]
6. Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family.
Nissen KB; Haugaard-Kedström LM; Wilbek TS; Nielsen LS; Åberg E; Kristensen AS; Bach A; Jemth P; Strømgaard K
PLoS One; 2015; 10(2):e0117668. PubMed ID: 25658767
[TBL] [Abstract][Full Text] [Related]
7. Discovery, structure-activity relationship studies, and crystal structure of nonpeptide inhibitors bound to the Shank3 PDZ domain.
Saupe J; Roske Y; Schillinger C; Kamdem N; Radetzki S; Diehl A; Oschkinat H; Krause G; Heinemann U; Rademann J
ChemMedChem; 2011 Aug; 6(8):1411-22. PubMed ID: 21626699
[TBL] [Abstract][Full Text] [Related]
8. A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage.
Bach A; Clausen BH; Møller M; Vestergaard B; Chi CN; Round A; Sørensen PL; Nissen KB; Kastrup JS; Gajhede M; Jemth P; Kristensen AS; Lundström P; Lambertsen KL; Strømgaard K
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3317-22. PubMed ID: 22343531
[TBL] [Abstract][Full Text] [Related]
9. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity.
van den Berk LC; Landi E; Walma T; Vuister GW; Dente L; Hendriks WJ
Biochemistry; 2007 Nov; 46(47):13629-37. PubMed ID: 17979300
[TBL] [Abstract][Full Text] [Related]
10. Identification of small-molecule compounds targeting the dishevelled PDZ domain by virtual screening and binding studies.
Choi J; Ma S; Kim HY; Yun JH; Heo JN; Lee W; Choi KY; No KT
Bioorg Med Chem; 2016 Aug; 24(15):3259-66. PubMed ID: 27112452
[TBL] [Abstract][Full Text] [Related]
11. Development of Peptide-Based PDZ Domain Inhibitors.
Essig DJ; Balboa JR; Strømgaard K
Methods Mol Biol; 2021; 2256():157-177. PubMed ID: 34014522
[TBL] [Abstract][Full Text] [Related]
12. Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.
Bach A; Pedersen SW; Dorr LA; Vallon G; Ripoche I; Ducki S; Lian LY
Sci Rep; 2015 Jul; 5():12157. PubMed ID: 26177569
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screen for small molecule inhibitors of Mint1-PDZ domains.
Chen X; Longgood JC; Michnoff C; Wei S; Frantz DE; Bezprozvanny L
Assay Drug Dev Technol; 2007 Dec; 5(6):769-83. PubMed ID: 18078379
[TBL] [Abstract][Full Text] [Related]
14. Impaired synaptic clustering of postsynaptic density proteins and altered signal transmission in hippocampal neurons, and disrupted learning behavior in PDZ1 and PDZ2 ligand binding-deficient PSD-95 knockin mice.
Nagura H; Ishikawa Y; Kobayashi K; Takao K; Tanaka T; Nishikawa K; Tamura H; Shiosaka S; Suzuki H; Miyakawa T; Fujiyoshi Y; Doi T
Mol Brain; 2012 Dec; 5():43. PubMed ID: 23268962
[TBL] [Abstract][Full Text] [Related]
15. Structure of the first PDZ domain of human PSD-93.
Fiorentini M; Nielsen AK; Kristensen O; Kastrup JS; Gajhede M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Dec; 65(Pt 12):1254-7. PubMed ID: 20054121
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies.
Shan J; Zhang X; Bao J; Cassell R; Zheng JJ
Chem Biol Drug Des; 2012 Apr; 79(4):376-83. PubMed ID: 22172211
[TBL] [Abstract][Full Text] [Related]
17. Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95.
Long JF; Tochio H; Wang P; Fan JS; Sala C; Niethammer M; Sheng M; Zhang M
J Mol Biol; 2003 Mar; 327(1):203-14. PubMed ID: 12614619
[TBL] [Abstract][Full Text] [Related]
18. Inhalational anesthetics disrupt postsynaptic density protein-95, Drosophila disc large tumor suppressor, and zonula occludens-1 domain protein interactions critical to action of several excitatory receptor channels related to anesthesia.
Tao F; Chen Q; Sato Y; Skinner J; Tang P; Johns RA
Anesthesiology; 2015 Apr; 122(4):776-86. PubMed ID: 25654436
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding of the second PDZ domain regulates clustering of PSD-95 with the Kv1.4 potassium channel.
Imamura F; Maeda S; Doi T; Fujiyoshi Y
J Biol Chem; 2002 Feb; 277(5):3640-6. PubMed ID: 11723117
[TBL] [Abstract][Full Text] [Related]
20. Ensemble-Based Analysis of the Dynamic Allostery in the PSD-95 PDZ3 Domain in Relation to the General Variability of PDZ Structures.
Dudola D; Hinsenkamp A; Gáspári Z
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
